| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10143948 | Journal of Global Antimicrobial Resistance | 2018 | 6 Pages |
Abstract
Micafungin was clinically effective for the treatment of invasive Candida and Aspergillus infections, and usage did not increase the risk of liver dysfunction even in patients with abnormal ALT at baseline.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
David A. Enoch, Michael E. Murphy, Christianne Micallef, Huina Yang, Nicholas M. Brown, Sani H. Aliyu,